Insider · CIK 0001643070

Roemer Alan S.

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001643070

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-22	INABIN8BIO, INC.A Award	Director	AAward	+36.2K sh	$1.38	+$50K	49,514
2025-05-08	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+63.2K sh	—	—	63,150
2025-04-30	INABIN8BIO, INC.M Exercise/Conversion	Director	MExercise/Conversion	+102K sh	$0.18	+$18.9K	387,489
2025-04-30	INABIN8BIO, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11K sh	$0.18	+$2,028.4	398,489
2025-04-30	INABIN8BIO, INC. · Series A Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−102K sh	—	—	0
2025-04-30	INABIN8BIO, INC. · Series B Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11K sh	—	—	0
2025-04-27	INABIN8BIO, INC. · Series A Warrants (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−102K sh	—	—	0
2025-04-27	INABIN8BIO, INC. · Series A Warrants (right to buy)A Award	Director	AAward	+102K sh	—	—	102,459
2025-04-27	INABIN8BIO, INC. · Series B Warrants (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−102K sh	—	—	0
2025-04-27	INABIN8BIO, INC. · Series B Warrants (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2025-04-27	INABIN8BIO, INC. · Series B Warrants (right to buy)A Award	Director	AAward	+91.5K sh	—	—	91,459
2024-12-19	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+93.2K sh	—	—	93,242
2024-10-04	INABIN8BIO, INC.A Award	Director	AAward	+127K sh	—	—	285,030
2024-10-04	INABIN8BIO, INC. · Series A Warrants (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−102K sh	—	—	0
2024-10-04	INABIN8BIO, INC. · Series A Warrants (right to buy)A Award	Director	AAward	+102K sh	—	—	102,459
2024-10-04	INABIN8BIO, INC. · Series C Warrants (right to buy)A Award	Director	AAward	+127K sh	—	—	126,582
2024-06-12	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+33.7K sh	—	—	33,650
2023-12-13	INABIN8BIO, INC.A Award	Director	AAward	+102K sh	—	—	158,448
2023-12-13	INABIN8BIO, INC. · Series A Warrants (right to buy)A Award	Director	AAward	+102K sh	—	—	102,459
2023-12-13	INABIN8BIO, INC. · Series B Warrants (right to buy)A Award	Director	AAward	+102K sh	—	—	102,459
2023-11-22	NexImmune, Inc.S Sale	Director	SSale	−3,992 sh	$1.94	−$7,758.053	0
2023-11-21	NexImmune, Inc.S Sale	Director	SSale	−3,833 sh	$2.16	−$8,287.329	3,992
2023-07-05	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	44,983
2023-06-15	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+85K sh	—	—	85,000
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−61.7K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+61.7K sh	—	—	61,678
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,556 sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,556 sh	—	—	9,556
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.1K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+23.1K sh	—	—	23,122
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,856 sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,856 sh	—	—	3,856
2022-08-16	INABIN8BIO, INC.P Purchase	Director	PPurchase	+26.3K sh	$1.90	+$50K	55,989
2022-06-13	NexImmune, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+61.7K sh	—	—	61,678
2022-06-01	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2022-06-01	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2021-12-21	NexImmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.6K sh	$2.42	+$30.6K	140,618
2021-12-21	NexImmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.6K sh	$2.58	+$32.6K	153,252
2021-12-21	NexImmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+42.4K sh	$4.31	+$183K	195,641
2021-12-21	NexImmune, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.6K sh	—	—	0
2021-12-21	NexImmune, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.6K sh	—	—	0
2021-12-21	NexImmune, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−42.4K sh	—	—	3,856
2021-11-19	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+86.3K sh	—	—	86,258
2021-07-29	INABIN8BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+85K sh	—	—	85,016
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+4,110 sh	—	—	89,126
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+26.6K sh	—	—	115,716
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+12.3K sh	—	—	127,984
2021-02-17	NexImmune, Inc.Series A Preferred StockC Conversion	Director	CConversion	−85K sh	—	—	0
2021-02-17	NexImmune, Inc.Series A2 Preferred StockC Conversion	Director	CConversion	−4,110 sh	—	—	0

Recent filings

Accepted (ET)
Dec 234
Roemer Alan S.0001643070-25-000005
SEC(opens sec.gov)
May 124
Roemer Alan S.0001415889-25-012649
SEC(opens sec.gov)
May 74
Roemer Alan S.0001415889-25-012287
SEC(opens sec.gov)
Dec 234
Roemer Alan S.0001415889-24-030060
SEC(opens sec.gov)
Oct 84
Roemer Alan S.0001415889-24-024868
SEC(opens sec.gov)
Jun 144
Roemer Alan S.0001415889-24-016964
SEC(opens sec.gov)
Dec 154
Roemer Alan S.0001209191-23-058719
SEC(opens sec.gov)

Companies

Address

C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330

NEW YORK, NY, 10118